arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Concentrix Corp

CNXC
$25.70 ▼ -0.63 (-2.39%) at close
Industrials ·Services-Business Services, NEC ·USServices-Business Services, NEC
28 Visible periods
33 Metrics
Peer-ranked Benchmarks
Price Chart
22
Health
Poor
Bearish
auto_awesome

Analytical Summary

Concentrix Corp faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.6B
Dividend Yield
Revenue Growth 1.9%
Op. Margin 3.9%
ROIC 1.1%
FCF / Share $3.45
Trailing P/E 29.9x
Price / Book 0.6x
FCF Yield 13.4%
Debt / Equity 1.46
info Valuation on last close. End-of-day price, Aug 7, 2026.

28-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.46B
↑ +1.9%
Net Income Profit after all expenses
$55.28M
↑ +31.3%
Operating Margin Operating profit as % of sales
3.9%
↓ -18.3% 16th
FCF / Share Free cash flow per share
$3.45
↑ +254.0%
Long-Term Debt Long-term obligations
$3.93B
↓ -1.5%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
26
Returns
17
Financial Health
27
Cash Quality
14

Dividend History

Dividend / share · sourced from SEC filings
$0.33 Latest / share
+21.0% YoY
+10.0% 4-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 28 quarters